Role of P2Y12 inhibitor therapy in ACS and after PCI: Twilight and ISAR-React 5

1 Views
Published
APSC Journal Club Series - Hot Topics in Cardiology
Co-organized by APSC Emerging Leaders
Role of P2Y12 inhibitor therapy in ACS and after PCI: Twilight and ISAR-React 5
30 November 2021, Tuesday 1800-1900 Singapore Time (UTC +8)

Chair:
Clin A/Prof Jack Tan
Deputy Head National Heart Centre Singapore
Head Cardiology Sengkang General Hospital
Immediate Past President Asian Pacific Society of Cardiology
President, International Society of Cardiovascular Pharmacotherapy

Co-chair:
Clin A/Prof Jonathan Yap
Consultant
Department of Cardiology
National Heart Centre
Singapore

Speaker:
Dr Derek Lee
Cardiologist
Queen Elizabeth Hospital
Hong Kong
ISAR React

Dr Bernard Benjamin Albano
Interventional Cardiology
Philippine Heart Centre
Singapore General Hospital
Philippines
Twilight

Moderators:
Prof Derek Chew
Matthew Flinders Fellow and
Professor in Cardiology
College of Medicine and Public Health
Adelaide, Australia

Endorsed by:
Singapore Cardiac Society
International Society of Cardiovascular Pharmacotherapy
Category
Management
Be the first to comment